{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:14:58Z","timestamp":1775643298661,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reseau SIDA of the Fonds de Recherche du Quebec"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1093\/jac\/dkv176","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T23:59:07Z","timestamp":1436054347000},"page":"2810-2815","source":"Crossref","is-referenced-by-count":10,"title":["Dolutegravir maintains a durable effect against HIV replication in tissue culture even after drug washout"],"prefix":"10.1093","volume":"70","author":[{"given":"Nathan","family":"Osman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibault","family":"Mespl\u00e8de","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K.","family":"Quashie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Zanichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Wainberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,7,4]]},"reference":[{"key":"2015091109281178000_70.10.2810.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60597-2"},{"key":"2015091109281178000_70.10.2810.2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01534-07"},{"key":"2015091109281178000_70.10.2810.3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01075-09"},{"key":"2015091109281178000_70.10.2810.4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350901400108","article-title":"Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes","volume":"14","author":"Maiga","year":"2009","journal-title":"Antivir Ther"},{"key":"2015091109281178000_70.10.2810.5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01209-10"},{"key":"2015091109281178000_70.10.2810.6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/13543784.2011.562189","article-title":"S\/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges","volume":"20","author":"Lenz","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"2015091109281178000_70.10.2810.7","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2010.501078"},{"key":"2015091109281178000_70.10.2810.8","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06591-11"},{"key":"2015091109281178000_70.10.2810.9","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-22"},{"key":"2015091109281178000_70.10.2810.10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku199"},{"key":"2015091109281178000_70.10.2810.11","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-11-7"},{"key":"2015091109281178000_70.10.2810.12","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000199"},{"key":"2015091109281178000_70.10.2810.13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000606"},{"key":"2015091109281178000_70.10.2810.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61221-0"},{"key":"2015091109281178000_70.10.2810.15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis750"},{"key":"2015091109281178000_70.10.2810.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61853-4"},{"key":"2015091109281178000_70.10.2810.17","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.7448\/IAS.17.4.19490","article-title":"Once-daily dolutegravir is superior to once-daily darunavir\/ritonavir in treatment-na\u00efve HIV-1-positive individuals: 96 week results from FLAMINGO","volume":"17","author":"Molina","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2015091109281178000_70.10.2810.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00157-11"},{"key":"2015091109281178000_70.10.2810.19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-349-11888-5_4","article-title":"Infectivity assay (virus yield assay)","volume-title":"Techniques in HIV Research","author":"Johnson","year":"1990"},{"key":"2015091109281178000_70.10.2810.20","doi-asserted-by":"publisher","DOI":"10.1089\/088922203769232548"},{"key":"2015091109281178000_70.10.2810.21","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-015-0153-9"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/70\/10\/2810\/2474690\/dkv176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T16:41:40Z","timestamp":1652805700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,4]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,9,11]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1093\/jac\/dkv176"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv176","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,4]]}}}